Scilex Holding SCLX
NASDAQ SCLX
$5.73 -0.07 (-1.21%)
At close: Aug 21, 2026 · 4:00 PM EDT

Scilex Holding (SCLX) Cost of Revenue (2022 - 2026)

Scilex Holding (SCLX) posted quarterly Cost of Revenue of $4.4 million for Q1 2026, up 221.32% year-over-year from $1.4 million in Q1 2025, and up 70.12% quarter-over-quarter from $2.6 million in Q4 2025.

Scilex Holding (SCLX) Cost of Revenue (2022 - 2026) Analysis & Trends

Scilex Holding's Cost of Revenue history runs 5 years deep, the most recent figure standing at $4.4 million for Q1 2026.

  • In Q1 2026, Cost of Revenue rose 221.32% year-over-year to $4.4 million; the TTM figure through Mar 2026 stood at $13.7 million (down 4.01% YoY), while the FY2025 annual figure was $10.6 million, down 36.49% from the prior year.
  • Cost of Revenue for Q1 2026 stood at $4.4 million, up from $2.6 million in the prior quarter.
  • The five-year high for Cost of Revenue was $4.7 million in Q4 2024, with the low at $1.1 million in Q1 2022.
  • The 5-year median for Cost of Revenue is $3.6 million (2022), against an average of $3.4 million.
  • The sharpest annual moves came in 2025 and 2026: Cost of Revenue tumbled 63.96% in 2025, then soared 221.32% in 2026.
  • Scilex Holding's Cost of Revenue stood at $4.5 million in 2022, then gained by 0.18% to $4.5 million in 2023, then advanced by 3.76% to $4.7 million in 2024, then plunged by 44.28% to $2.6 million in 2025, then surged by 70.12% to $4.4 million in 2026.
  • Business Quant data shows SCLX's Cost of Revenue at $4.4 million in Q1 2026, $2.6 million in Q4 2025, and $3.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn 8.05 Bn
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn 4.29 Bn
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn 4.40 Bn
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn 3.71 Bn
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn 2.52 Bn
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn 2.81 Bn
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn 1.58 Bn
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn 4.09 Bn
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn 3.04 Bn
10 Scilex Holding 39.22 Mn -73.57 Mn 3.97 Mn 3.68 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 4.45 Mn
Mar 31, 2026 4.45 Mn
Dec 31, 2025 2.61 Mn
Dec 31, 2025 2.61 Mn
Sep 30, 2025 3.33 Mn
Sep 30, 2025 3.33 Mn
Jun 30, 2025 3.27 Mn
Jun 30, 2025 3.27 Mn
Mar 31, 2025 1.38 Mn
Mar 31, 2025 1.38 Mn
Dec 31, 2024 4.69 Mn
Dec 31, 2024 4.69 Mn
Sep 30, 2024 3.77 Mn
Sep 30, 2024 3.77 Mn
Jun 30, 2024 4.39 Mn
Jun 30, 2024 4.39 Mn
Mar 31, 2024 3.84 Mn
Mar 31, 2024 3.84 Mn
Dec 31, 2023 4.52 Mn
Dec 31, 2023 4.52 Mn